CLRBW Insider Trading - Cellectar Biosciences, Inc. Warrants expiring 8/20/2019

Pontuação de Sentimento de Insider

A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.

É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com a maior acumulação de insiders.

Veja as Ações de Maior Classificação

Pontuação de Sentimento dos Oficiais

A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.

Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.

Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com maior sentimento dos insiders.

Veja as Ações de Maior Classificação

Principais Métricas de Insider

Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.

Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).

Número Líquido de Insiders Comprando (Classificação)

N/A

Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).

Percentual do Float Comprado por Insiders (Classificação)

N/A

Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.

Gráfico de Negociação de Insider

Cellectar Biosciences, Inc. Warrants expiring 8/20/2019 negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.

Roster de Insider e Métricas de Lucratividade

Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.

See our leaderboard of most profitable insider traders.

Insider	Lucro Médio (%)	Ações Possuídas	Ajuste de Divisão

Report errors via our new Insider Auditing Tool

Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação	Insider	Reported Shares	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custo	Dias até Máx	Preço em Máx	Lucro Máximo ($)	Retorno Máximo (%)
2026-05-07	CARUSO JAMES V	8,680	2.8800	8,680	2.8800	24,998	0	3.3000	3,646	14.59
2026-05-07	Longcor Jarrod	8,680	2.8800	8,680	2.8800	24,998
2025-07-02	Kolean Chad J	5,000	4.9900	5,000	4.9900	24,950
2025-07-02	Longcor Jarrod	10,000	4.9900	10,000	4.9900	49,900
2025-07-02	CARUSO JAMES V	10,000	4.9900	10,000	4.9900	49,900
2025-01-10	Longcor Jarrod	30,000	0.2800	1,000	8.4000	8,400
2021-09-14	Swirsky Douglas J	25,000	1.0400	1,250	20.8000	26,000
2021-09-03	DRISCOLL FREDERICK W	19,417	1.0426	971	20.8520	20,244
2021-03-04	CARUSO JAMES V	5,100	1.6978	255	33.9560	8,659

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019 Insider Trades

Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo

Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação	Insider	Reported Shares	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custo	Dias até Mín	Preço em Mín	Máxima Perda Evitada ($)	Máxima Perda Evitada (%)
2025-12-12	NEIS JOHN	198	3.6969	198	3.6969	732	110	2.4900	-238	-32.56
2018-11-29	HILL STEPHEN A	53	2.2100	3	44.2000	117
2018-11-29	HILL STEPHEN A	939	2.2101	47	44.2020	2,075

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

Histórico de Transações

Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.

Arquivo Data	Data da Operação	Formulário	Insider	Ticker	Título de Segurança	Código	Direto	Preço de Exercício Preço Unitário	Preço por Unidade	Unidades Alteradas	Valor Alterado (1K)	Opções Restantes	Ações Restantes
2026-05-11	2026-05-07	4	Longcor Jarrod	CLRB	Common Stock	P - Purchase	D		2.8800	8,680	25		20,451
2026-05-11	2026-05-07	4	CARUSO JAMES V	CLRB	Common Stock	P - Purchase	D		2.8800	8,680	25		20,318
2025-12-16	2025-12-12	4	NEIS JOHN	CLRB	Common Stock	S - Sale	I		3.6969	-198	-1		10
2025-07-03	2025-07-02	4	CARUSO JAMES V	CLRB	Common Stock	P - Purchase	D		4.9900	10,000	50		11,638
2025-07-03	2025-07-02	4	Longcor Jarrod	CLRB	Common Stock	P - Purchase	D		4.9900	10,000	50		12,768
2025-07-03	2025-07-02	4	Kolean Chad J	CLRB	Common Stock	P - Purchase	D		4.9900	5,000	25		6,418
2025-03-12	2025-01-10	4	Longcor Jarrod	CLRB	Common Stock	P - Purchase	D		0.2800	30,000	8		83,141
2023-12-12	2023-12-08	4	Lea Darrell Shane	CLRB	Common Stock	A - Award	D			39,599			39,599
2023-12-12	2023-12-08	4	Kolean Chad J	CLRB	Common Stock	A - Award	D			42,554			42,578
2023-12-12	2023-12-08	4	Shustov Andrei	CLRB	Common Stock	A - Award	D			47,856			55,038
2023-12-12	2023-12-08	4	CARUSO JAMES V	CLRB	Common Stock	A - Award	D			40,596			49,236
2023-12-12	2023-12-08	4	Longcor Jarrod	CLRB	Common Stock	A - Award	D			42,927			53,141
2023-03-16		3	Shustov Andrei	CLRB	Common Stock		D						7,182
2022-04-15		3/A	Kolean Chad J	CLRB	Common Stock		D						240
2022-02-24	2022-02-22	4	Kolean Chad J	CLRB	Stock option (right to buy)	A - Award	D	0.49		150,000		150,000
2022-01-27	2022-01-25	4	CARUSO JAMES V	CLRB	Stock option (right to buy)	A - Award	D	0.55		1,419,000		1,419,000
2022-01-27	2022-01-25	4	Elefant Dov	CLRB	Stock option (right to buy)	A - Award	D	0.55		422,000		422,000
2022-01-27	2022-01-25	4	Longcor Jarrod	CLRB	Stock option (right to buy)	A - Award	D	0.55		475,000		475,000
2021-09-14	2021-09-14	4	Swirsky Douglas J	CLRB	Common Stock	P - Purchase	D		1.0400	25,000	26		25,000
2021-09-07	2021-09-03	4	DRISCOLL FREDERICK W	CLRB	Common Stock	P - Purchase	D		1.0426	19,417	20		19,417
2021-07-02	2021-06-30	4	NEIS JOHN	CLRB	Stock option (right to buy)	A - Award	D	1.19		78,000		78,000
2021-07-02	2021-06-30	4	DRISCOLL FREDERICK W	CLRB	Stock option (right to buy)	A - Award	D	1.19		78,000		78,000
2021-07-02	2021-06-30	4	Swirsky Douglas J	CLRB	Stock option (right to buy)	A - Award	D	1.19		117,000		117,000
2021-07-02	2021-06-30	4	Loren Stefan	CLRB	Stock option (right to buy)	A - Award	D	1.19		78,000		78,000
2021-07-02	2021-06-30	4	Chanan-Khan Asher	CLRB	Stock option (right to buy)	A - Award	D	1.19		78,000		78,000
2021-03-19	2021-03-18	4	NEIS JOHN	CLRB	Series A Warrants	S - Sale	D	30.40	0.2522	-23,232	-6	0
2021-03-19	2021-03-17	4	NEIS JOHN	CLRB	Series A Warrants	S - Sale	D	30.40	0.2775	-58,640	-16	23,232
2021-03-16	2021-03-16	4	NEIS JOHN	CLRB	Series A Warrants	S - Sale	D	30.40	0.3091	-100,515	-31	81,872
2021-03-16	2021-03-15	4	NEIS JOHN	CLRB	Series A Warrants	S - Sale	D	30.40	0.2652	-11,200	-3	182,387
2021-03-16	2021-03-12	4	NEIS JOHN	CLRB	Series A Warrants	S - Sale	D	30.40	0.2668	-41,155	-11	193,587
2021-03-05	2021-03-04	4	Elefant Dov	CLRB	Stock option (right to buy)	A - Award	D	1.74		430,000		430,000
2021-03-05	2021-03-04	4	CARUSO JAMES V	CLRB	Series A Warrants	S - Sale	D	30.40	0.1857	46,948	9	0
2021-03-05	2021-03-04	4	CARUSO JAMES V	CLRB	Stock option (right to buy)	A - Award	D	1.74		1,600,000		1,600,000
2021-03-05	2021-03-04	4	CARUSO JAMES V	CLRB	Common Stock	P - Purchase	D		1.6978	5,100	9		86,401
2021-03-05	2021-03-04	4	Friend John E. II	CLRB	Stock option (right to buy)	A - Award	D	1.74		330,000		330,000
2021-03-05	2021-03-04	4	Longcor Jarrod	CLRB	Stock option (right to buy)	A - Award	D	1.74		450,000		450,000
2020-12-28	2020-12-28	4	Elefant Dov	CLRB	Common Stock	P - Purchase	D		1.3500	7,407	10		11,755
2020-12-28	2020-12-28	4	Longcor Jarrod	CLRB	Common Stock	P - Purchase	D		1.3500	29,630	40		102,148
2020-12-28	2020-12-28	4	CARUSO JAMES V	CLRB	Common Stock	P - Purchase	D		1.3500	37,037	50		81,301
2020-07-06		3	Friend John E. II	CLRB	Common Stock		D						6,666
2020-07-06		3	Friend John E. II	CLRB	Common Stock		D						6,666
2020-07-06		3	Friend John E. II	CLRB	Common Stock		D						6,666
2020-07-06	2020-07-01	4	Friend John E. II	CLRB	Stock option (right to buy)	A - Award	D	1.34		100,000		100,000
2020-06-25	2020-06-24	4	HILL STEPHEN A	CLRB	Stock option (right to buy)	A - Award	D	1.28		50,000		50,000
2020-06-25	2020-06-24	4	NEIS JOHN	CLRB	Stock option (right to buy)	A - Award	D	1.28		50,000		50,000
2020-06-25	2020-06-24	4	Loren Stefan	CLRB	Stock option (right to buy)	A - Award	D	1.28		50,000		50,000
2020-06-25	2020-06-24	4	DRISCOLL FREDERICK W	CLRB	Stock option (right to buy)	A - Award	D	1.28		50,000		50,000
2020-06-25	2020-06-24	4	Swirsky Douglas J	CLRB	Stock option (right to buy)	A - Award	D	1.28		80,000		80,000
2020-06-08	2020-06-04	4	HILL STEPHEN A	CLRB	Common Stock	P - Purchase	D		1.0799	18,000	19		18,000
2020-06-08	2020-06-05	4	CARUSO JAMES V	CLRB	Series H Warrants	P - Purchase	D	1.21	0.0100	10,870	0	10,870
2020-06-08	2020-06-05	4	CARUSO JAMES V	CLRB	Common Stock	P - Purchase	D		1.1450	21,740	25		44,264
2020-06-08	2020-06-05	4	Longcor Jarrod	CLRB	Series H Warrants	P - Purchase	D	1.21	0.0100	32,609	0	32,609
2020-06-08	2020-06-05	4	Longcor Jarrod	CLRB	Common Stock	P - Purchase	D		1.1450	65,218	75		72,518
2020-06-08	2020-06-05	4	Elefant Dov	CLRB	Series H Warrants	P - Purchase	D	1.21	0.0100	2,174	0	2,174
2020-06-08	2020-06-05	4	Elefant Dov	CLRB	Common Stock	P - Purchase	D		1.1450	4,348	5		4,348
2020-03-05	2020-02-03	4/A	CARUSO JAMES V	CLRB	Stock option (right to buy)	A - Award	D	2.71		100,000		100,000
2020-03-05	2020-02-03	4/A	Longcor Jarrod	CLRB	Stock option (right to buy)	A - Award	D	2.71		40,000		40,000
2020-03-05	2020-02-03	4/A	Elefant Dov	CLRB	Stock Option (right to buy)	A - Award	D	2.71		10,000		10,000
2020-02-04	2020-02-03	4	CARUSO JAMES V	CLRB	Common stock	A - Award	D		2.7100	100,000	271		100,000
2020-02-04	2020-02-03	4	Longcor Jarrod	CLRB	Common stock	A - Award	D		2.7100	40,000	108		40,000
2020-02-04	2020-02-03	4	Elefant Dov	CLRB	Common stock	A - Award	D		2.7100	10,000	27		10,000
2020-01-08	2020-01-06	4	Grachev Igor D	CLRB	Stock Option (right to buy)	A - Award	D	2.46		80,000		80,000
2019-09-11	2019-09-10	4	Elefant Dov	CLRB	Stock Option (right to buy)	A - Award	D	2.32		90,000		90,000
2019-06-14	2019-06-13	4	NEIS JOHN	CLRB	Stock option (right to buy)	A - Award	D	2.15		6,500		6,500
2019-06-14	2019-06-13	4	Swirsky Douglas J	CLRB	Stock option (right to buy)	A - Award	D	2.15		9,750		9,750
2019-06-14	2019-06-13	4	DRISCOLL FREDERICK W	CLRB	Stock option (right to buy)	A - Award	D	2.15		6,500		6,500
2019-06-14	2019-06-13	4	Loren Stefan	CLRB	Stock option (right to buy)	A - Award	D	2.15		6,500		6,500
2019-06-14	2019-06-13	4	HILL STEPHEN A	CLRB	Stock option (right to buy)	A - Award	D	2.15		6,500		6,500
2019-03-01	2019-02-28	4	Longcor Jarrod	CLRB	Common Stock	P - Purchase	D		2.0025	100	0		7,300
2019-01-18	2019-01-17	4	CARUSO JAMES V	CLRB	Stock option (right to buy)	A - Award	D	1.99		75,000		75,000
2019-01-18	2019-01-17	4	POSNER BRIAN M	CLRB	Stock option (right to buy)	A - Award	D	1.99		30,000		30,000
2019-01-18	2019-01-17	4	Longcor Jarrod	CLRB	Stock option (right to buy)	A - Award	D	1.99		30,000		30,000
2018-11-30	2018-11-30	4	CARUSO JAMES V	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		2.2820	1,000	2		22,354
2018-11-30	2018-11-29	4	HILL STEPHEN A	CLRB	Warrants	S - Sale	D	468.00	0.0510	530	0	0
2018-11-30	2018-11-29	4	HILL STEPHEN A	CLRB	Series A Warrants	S - Sale	D	30.40	0.0977	9,390	1	0
2018-11-30	2018-11-29	4	HILL STEPHEN A	CLRB	Common Stock	S - Sale	D		2.2100	-53	-0		0
2018-11-30	2018-11-29	4	HILL STEPHEN A	CLRB	Common Stock	S - Sale	D		2.2101	-939	-2		53
2018-10-15	2018-10-12	4	DRISCOLL FREDERICK W	CLRB	Stock option (right to buy)	A - Award	D	2.61		13,000		13,000
2018-10-15	2018-10-12	4	HILL STEPHEN A	CLRB	Stock option (right to buy)	A - Award	D	2.61		13,000		13,000
2018-10-15	2018-10-12	4	Loren Stefan	CLRB	Stock option (right to buy)	A - Award	D	2.61		13,000		13,000
2018-10-15	2018-10-12	4	NEIS JOHN	CLRB	Stock option (right to buy)	A - Award	D	2.61		13,000		13,000
2018-10-15	2018-10-12	4	CARUSO JAMES V	CLRB	Stock option (right to buy)	A - Award	D	2.61		150,000		150,000
2018-10-15	2018-10-12	4	Longcor Jarrod	CLRB	Stock option (right to buy)	A - Award	D	2.61		63,000		63,000
2018-10-15	2018-10-12	4	Friend John E. II	CLRB	Stock option (right to buy)	A - Award	D	2.61		63,000		63,000
2018-10-15	2018-10-12	4	POSNER BRIAN M	CLRB	Stock option (right to buy)	A - Award	D	2.61		54,000		54,000
2018-10-15	2018-10-12	4	Swirsky Douglas J	CLRB	Stock option (right to buy)	A - Award	D	2.61		19,500		19,500
2018-08-17	2018-08-16	4	Longcor Jarrod	CLRB	Common Stock	P - Purchase	D		2.7100	500	1		7,200
2018-04-06	2018-04-06	4	POSNER BRIAN M	CLRB	Stock option (right to buy)	A - Award	D	1.17		80,000		80,000
2018-03-14	2018-03-12	4	CARUSO JAMES V	CLRB	Common Stock	S - Sale	D		1.1972	-34,000	-41		213,548
2018-03-14	2018-03-13	4	Longcor Jarrod	CLRB	Common Stock	S - Sale	D		1.1844	-13,000	-15		67,000
2017-11-16	2017-11-14	4	NEIS JOHN	CLRB	Common Stock, par value $0.00001 per share	S - Sale	I		1.4942	-5,214	-8		626,103
2017-09-25	2017-09-18	4	Longcor Jarrod	CLRB	Employee Stock Option (right to buy)	A - Award	D	1.83		25,000		25,000
2017-06-01	2017-05-31	4	Loren Stefan	CLRB	Stock option (right to buy)	A - Award	D	1.74		10,000		10,000
2017-06-01	2017-05-31	4	NEIS JOHN	CLRB	Stock option (right to buy)	A - Award	D	1.74		10,000		10,000
2017-06-01	2017-05-31	4	DRISCOLL FREDERICK W	CLRB	Stock option (right to buy)	A - Award	D	1.74		10,000		10,000
2017-06-01	2017-05-31	4	HILL STEPHEN A	CLRB	Stock option (right to buy)	A - Award	D	1.74		10,000		10,000
2017-06-01	2017-05-31	4	Swirsky Douglas J	CLRB	Stock option (right to buy)	A - Award	D	1.74		10,000		10,000
2017-04-20	2017-04-18	4	CARUSO JAMES V	CLRB	Common stock	A - Award	D			200,000			247,548
2017-04-20	2017-04-18	4	Longcor Jarrod	CLRB	Common stock	A - Award	D			80,000			80,000
2017-04-20	2017-04-18	4	Kolean Chad J	CLRB	Common stock	A - Award	D			80,000			80,000
2017-04-18	2017-04-17	4	Friend John E. II	CLRB	Common stock	A - Award	D			100,000			100,000
2016-11-30	2016-11-29	4	NEIS JOHN	CLRB	Series C Warrants (right to buy)	P - Purchase	I	1.50	0.0100	333,333	3	607,946
2016-11-30	2016-11-29	4	NEIS JOHN	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	I		1.4900	333,333	497		631,317
2016-11-01	2016-10-31	4	Hertzberg Richard	clrB	Cellectar Biosciences, Inc. common stock (CLRB)	S - Sale	D		2.0290	-21,000	-43		280,000
2016-11-01	2016-08-09	4	Hertzberg Richard	clrB	Cellectar Biosciences Inc. Warrant (CLRBW)	S - Sale	D	46.80	1.7500	-40,916	-72	0
2016-08-12	2016-07-15	4	Longcor Jarrod	CLRB	Employee Stock Option (right to buy)	A - Award	D	2.93		75,000		75,000
2016-07-07	2016-07-05	4	Loren Stefan	CLRB	Stock option (right to buy)	A - Award	D	3.34	0.0100	22,500	0	23,500
2016-07-06	2016-07-05	4	NEIS JOHN	CLRB	Stock option (right to buy)	A - Award	D	3.34	0.0100	22,500	0	24,750
2016-07-06	2016-07-05	4	HILL STEPHEN A	CLRB	Stock option (right to buy)	A - Award	D	3.34	0.0100	22,500	0	25,434
2016-06-14	2015-12-28	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		0.7200	75,000	54		75,000
2016-06-14	2015-12-24	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		0.7900	50,000	40		50,000
2016-06-14	2015-12-22	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		0.9100	5,000	5		5,000
2016-06-14	2015-12-16	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		0.9100	19,592	18		19,592
2016-06-14	2015-12-11	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		0.9240	16,250	15		16,250
2016-06-14	2015-12-08	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		0.9225	10,000	9		10,000
2016-06-14	2014-10-03	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		2.2500	10,000	22		10,000
2016-06-14	2014-09-19	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		2.6700	20,000	53		20,000
2016-06-14	2014-08-20	5	Hertzberg Richard	CLRB	Cellectar Biosciences Inc. Warrant (CLRBW)	P - Purchase	D	4.68	0.0100	409,158	4	409,158
2016-06-14	2014-08-20	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		3.7500	409,158	1,534		409,158
2016-06-14	2011-12-11	5	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. Warrant 12/5/2011	P - Purchase	D	12.00	0.0002	10,000	0	10,000
2016-06-14	2011-12-05	5	Hertzberg Richard	CLRB	Novelos Therapeutics, Inc. New (NVLT)	P - Purchase	D		12.0000	10,000	120		10,000
2016-06-14	2016-04-21	4	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc.	P - Purchase	D		1.9000	3,758	7		301,000
2016-06-14	2016-04-15	4	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. Series A Warrant (CLRBZ)	P - Purchase	D	3.04	0.0100	234,742	2	41,915
2016-06-14	2016-04-15	4	Hertzberg Richard	CLRB	Cellectar Biosciences, Inc. (CLRB) Common Stock	P - Purchase	D		2.1200	234,742	498		297,242
2016-05-23	2016-05-12	4	CARUSO JAMES V	CLRB	Stock option (right to buy)	A - Award	D	1.48	0.0100	200,000	2	237,500
2016-05-23	2016-05-12	4	Kolean Chad J	CLRB	Stock option (right to buy)	A - Award	D	1.48	0.0100	50,000	0	52,000
2016-05-23	2016-05-12	4	Weichert Jamey P	CLRB	Stock option (right to buy)	A - Award	D	1.48	0.0100	40,000	0	42,895
2016-04-25		3	WISCONSIN ALUMNI RESEARCH FOUNDATION	CLRB	Common Stock		D						938,968
2016-04-25		3	WISCONSIN ALUMNI RESEARCH FOUNDATION	CLRB	Common Stock		D						938,968
2016-04-21	2016-04-20	4	CARUSO JAMES V	CLRB	Series A Warrants	P - Purchase	D	3.04	0.0100	46,948	0	46,948
2016-04-21	2016-04-20	4	CARUSO JAMES V	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		2.1200	46,948	100		47,548
2016-04-21	2016-04-20	4	BERNS PAUL L	CLRB	Series A Warrants	P - Purchase	D	3.04	0.0100	117,371	1	117,371
2016-04-21	2016-04-20	4	BERNS PAUL L	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		2.1200	117,371	249		117,371
2016-04-21	2016-04-20	4	NEIS JOHN	CLRB	Series A Warrants	P - Purchase	I	3.04	0.0100	234,742	2	274,613
2016-04-21	2016-04-20	4	NEIS JOHN	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	I		2.1200	234,742	498		297,984
2016-04-21	2016-04-20	4	HILL STEPHEN A	CLRB	Series A Warrants	P - Purchase	D	3.04	0.0100	9,390	0	9,920
2016-04-21	2016-04-20	4	HILL STEPHEN A	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		2.1200	9,390	20		9,920
2016-01-04	2015-12-31	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.6955	-35,253	-25		0
2016-01-04	2015-12-30	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.6873	-64,747	-45		35,253
2015-12-30	2015-12-29	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.6929	-82,847	-57		100,000
2015-12-29	2015-12-28	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.6903	-150,975	-104		182,847
2015-12-29	2015-12-24	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.7596	-216,991	-165		333,822
2015-12-23	2015-12-22	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.9046	-7,938	-7		550,813
2015-12-22	2015-12-21	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.9223	-20,621	-19		558,751
2015-12-22	2015-12-18	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.8988	-7,000	-6		579,372
2015-12-18	2015-12-17	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.8816	-18,240	-16		586,372
2015-12-18	2015-12-16	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.8644	-52,985	-46		604,612
2015-12-16	2015-12-15	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		0.8243	-44,965	-37		657,597
2015-12-08	2015-12-04	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		1.0619	-49,950	-53		702,562
2015-12-08	2015-12-04	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		1.1400	-1,000	-1		752,512
2015-12-03	2015-12-01	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		1.0405	-42,110	-44		753,512
2015-12-01	2015-11-25	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		1.2026	-4,378	-5		795,622
2015-11-25	2015-11-24	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		1.2747	-67,102	-86		800,000
2015-11-25	2015-11-23	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		1.2110	-106,700	-129		867,102
2015-11-25	2015-11-24	4	CARUSO JAMES V	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		1.3020	1,000	1		6,000
2015-11-24	2015-11-20	4	CARUSO JAMES V	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		1.1593	1,000	1		5,000
2015-11-23	2015-11-20	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		1.1518	-88,745	-102		973,802
2015-11-23	2015-11-19	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		1.3794	-8,061	-11		10,625,547
2015-11-19	2015-11-19	4	CARUSO JAMES V	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		1.5000	2,000	3		4,000
2015-11-19	2015-11-18	4	CARUSO JAMES V	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		1.3949	2,000	3		2,000
2015-10-29	2015-10-28	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.0000	-99	-0		1,070,608
2015-10-26	2015-10-23	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.0000	-2,000	-4		1,070,707
2015-10-26	2015-10-22	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.0000	-6,866	-14		1,072,707
2015-10-08	2015-10-06	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.0000	-2,554	-5		1,079,573
2015-10-06	2015-10-05	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.1082	-2,800	-6		1,082,127
2015-10-06	2015-10-02	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.0000	-4,700	-9		1,084,927
2015-10-02	2015-10-01	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.0599	-21,600	-44		1,089,627
2015-10-02	2015-09-30	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.0000	-6,340	-13		1,111,227
2015-09-30	2015-09-29	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.1500	-1,701	-4		1,117,567
2015-09-30	2015-09-28	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.6500	-10,000	-26		1,119,268
2015-09-30	2015-09-28	4	AWM Investment Company, Inc. By Limited Partnerships	CLRB	Common Stock	S - Sale	I		2.1699	-13,100	-28		1,129,268
2015-06-10	2015-06-09	4	BERNS PAUL L	CLRB	Stock Option (right to buy)	A - Award	D	2.64		5,000		5,000
2015-06-10	2015-06-09	4	NEIS JOHN	CLRB	Stock Option (right to buy)	A - Award	D	2.64		5,000		5,000
2015-06-10	2015-06-09	4	HILL STEPHEN A	CLRB	Stock option (right to buy)	A - Award	D	2.64		5,000		5,000
2015-03-04	2015-02-26	4	HILL STEPHEN A	CLRB	Stock option (right to buy)	A - Award	D	2.69		5,500		5,500
2015-03-04	2015-02-26	4	BERNS PAUL L	CLRB	Stock Option (right to buy)	A - Award	D	2.69		5,000		5,000
2015-03-04	2015-02-26	4	NEIS JOHN	CLRB	Stock Option (right to buy)	A - Award	D	2.69		5,000		5,000
2015-03-04	2015-02-26	4	Genn John Patrick	CLRB	Stock option (right to buy)	A - Award	D	2.69		10,000		10,000
2014-12-18	2014-11-24	4	Szakacs Cameron	CLRB	Employee Stock Option (right to buy)	A - Award	D	2.74		50,000		50,000
2014-09-10	2014-09-08	4	MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships	CLRB	Common Stock	P - Purchase	I		3.0000	182	1		1,142,368
2014-09-09	2014-09-08	4	Genn John Patrick	CLRB	Stock purchase warrant (right to buy)	P - Purchase	D	4.68	0.0100	10,000	0	77,083
2014-09-09	2014-08-29	4	Genn John Patrick	CLRB	Stock purchase warrant (right to buy)	P - Purchase	D	4.68	0.0100	15,000	0	67,083
2014-09-09	2014-08-28	4	Genn John Patrick	CLRB	Stock purchase warrant (right to buy)	P - Purchase	D	4.68	0.0100	22,000	0	52,083
2014-09-09	2014-08-27	4	Genn John Patrick	CLRB	Stock purchase warrant (right to buy)	P - Purchase	D	4.68	0.0100	3,000	0	30,083
2014-09-08		3	MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships	CLRB	Common Stock		I						2,132,000
2014-09-08		3	MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships	CLRB	Common Stock		I						2,132,000
2014-09-08	2014-08-22	4	MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships	CLRB	Common Stock	P - Purchase	I		3.0000	5,699	17		1,142,186
2014-09-08	2014-08-19	4	MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships	CLRB	Common Stock	P - Purchase	I		3.0500	65,687	200		1,136,487
2014-09-08	2014-08-18	4	MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships	CLRB	Common Stock	P - Purchase	I		3.0500	4,800	15		1,070,800
2014-09-05		3	Cormorant Global Healthcare Master Fund, LP	CLRB	Common Stock		I						1,060,000
2014-09-05		3	Cormorant Global Healthcare Master Fund, LP	CLRB	Common Stock		I						1,060,000
2014-09-05		3	Cormorant Global Healthcare Master Fund, LP	CLRB	Common Stock		I						1,060,000
2014-09-05		3	Cormorant Global Healthcare Master Fund, LP	CLRB	Common Stock		I						1,060,000
2014-09-05		3	Cormorant Global Healthcare Master Fund, LP	CLRB	Common Stock		I						1,060,000
2014-08-22		3/A	NEIS JOHN See Foonote	CLRB	Common Stock, par value $0.00001 per share		I						363,715
2014-08-22	2014-08-20	4	HILL STEPHEN A	CLRB	Stock purchase warrant (right to buy)	P - Purchase	D	4.68	0.0100	5,300	0	21,351
2014-08-22	2014-08-20	4	HILL STEPHEN A	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		3.7500	5,300	20		5,300
2014-08-22	2014-08-20	4	NEIS JOHN See Foonote	CLRB	Stock Purchase Warrant (right to buy)	P - Purchase	I	4.68	0.0100	138,711	1	268,711
2014-08-22	2014-08-20	4	NEIS JOHN See Foonote	CLRB	Convertible Debenture (right to buy)	S - Sale	I	10.00	3.7500	-50,000	-188	0
2014-08-22	2014-08-20	4	NEIS JOHN See Foonote	CLRB	Stock Purchase Warrant (right to buy)	P - Purchase	I	4.68	0.0100	130,000	1	130,000
2014-08-22	2014-08-20	4	NEIS JOHN See Foonote	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	I		3.7500	138,711	520		632,426
2014-08-22	2014-08-20	4	NEIS JOHN See Foonote	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	I		3.7500	130,000	488		493,715
2014-08-22	2014-08-20	4	Pedder Simon	CLRB	Stock purchase warrant (right to buy)	P - Purchase	D	4.68	0.0100	13,300	0	277,578
2014-08-22	2014-08-20	4	Pedder Simon	CLRB	Common Stock, par value $0.00001 per share	P - Purchase	D		3.7500	13,300	50		13,300
2014-08-18		3	Genn John Patrick	CLRB	Common Stock, par value $0.00001 per share		D						7,064
2014-08-18		3	Genn John Patrick	CLRB	Common Stock, par value $0.00001 per share		D						7,064
2014-08-18		3	Weichert Jamey P	CLRB	Common Stock, par value $0.00001 per share		D						470,672
2014-08-18		3	Weichert Jamey P	CLRB	Common Stock, par value $0.00001 per share		D						470,672

Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo

Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo

Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)

Conversão de derivativo

Venda ou transferência de ativos de volta para a empresa

Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa

Doação de ativos pelo ou para o insider

Swaps de capital e transações de hedge similares

Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)

Uma transação voluntariamente reportada no Formulário 4

Outro (acompanhado de uma nota explicativa descrevendo a transação)

CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019 - Insider Trading and Ownership Report - SEC Form 3, 4, 5